300016 北陆药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.696-4.1880.6216.97510.945
总资产报酬率 ROA (%)0.405-2.5450.3944.3647.814
投入资产回报率 ROIC (%)0.447-2.8260.4434.9588.743

边际利润分析
销售毛利率 (%)55.61347.00855.39062.27066.581
营业利润率 (%)7.644-11.276-1.73414.78922.135
息税前利润/营业总收入 (%)13.796-6.3883.55417.41520.323
净利润/营业总收入 (%)5.600-9.341-0.59412.82618.613

收益指标分析
经营活动净收益/利润总额(%)100.58756.298165.68871.04284.777
价值变动净收益/利润总额(%)-17.8147.873-139.15422.08814.422
营业外收支净额/利润总额(%)0.2870.70810.020-3.938-5.344

偿债能力分析
流动比率 (X)3.4063.3323.8924.5743.933
速动比率 (X)2.7222.6502.9793.6983.592
资产负债率 (%)37.30336.64331.76628.1730.336
带息债务/全部投入资本 (%)33.47631.74827.09124.88328.427
股东权益/带息债务 (%)189.761204.874258.021292.957243.554
股东权益/负债合计 (%)155.363159.771198.395226.957182.303
利息保障倍数 (X)2.251-1.2850.6485.466-29.492

营运能力分析
应收账款周转天数 (天)76.30358.85656.39063.64471.717
存货周转天数 (天)242.634198.714277.242203.681155.894